Login
$NRXP
$2.13 -$0.02 (0.93%) Pre-market

Ownership

13F as of Q2 2026 · 43.2M shares outstanding

Who owns NRXP?

By type of holder
Institutions 27.0% Insiders 19.3% Everyone else 53.7%
Concentration Top 10 holders own 34.9%
B Group, Inc. 9.5% · Javitt Daniel C. 8.5%
Institutional ownership
27.0%
+12.6 pts vs last qtr
Institutional holders
47
+14 vs last qtr
Net shares bought
+5.4M
by institutions in Q2 2026
New / sold out
19 / 5
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • B Group, Inc. +1.1M
  • Ameriprise Financial Inc NEW +928.7K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • XTX Topco Ltd −60.2K
  • Headlands Technologies LLC SOLD OUT −39.4K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for NRX Pharmaceuticals, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2018–FY2025
+8085.7%
+108.37% a year
Each share's claim on the business
−98.8%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $13.2M
over 7 fiscal years
Diluted shares, split-adjusted
253.6K10.9M21.6M2018: 261.5K shares'182020: 3.4M shares'202021: 4.7M shares'212022: 6.6M shares'222023: 7.6M shares'232024: 10.6M shares'242025: 21.4M shares'25
Buybacks Stock-based comp
$0$3.9M$7.8M2018 buybacks: $02018 stock comp: $0'182020 buybacks: $02020 stock comp: $730.0K'202021 buybacks: $02021 stock comp: $7.8M'212022 buybacks: $02022 stock comp: $3.6M'222023 buybacks: $02023 stock comp: $387.0K'232024 buybacks: $02024 stock comp: $486.0K'242025 buybacks: $02025 stock comp: $228.0K'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years32% Under 1 year68%
Quarterly turnover
46.5%
of institutional shares changed hands
Top 10 managers, median time held
2 years

Super Investors

Investment managers reporting NRXP on Form 13F
BG
B Group, Inc.
Shares
4.1M
% of company
9.48%
Change vs last qtr
+1.1M (+36.4%)
Held since
Q1 '26
VC
Vanguard Capital Management LLC
Shares
1.6M
% of company
3.75%
Change vs last qtr
+458.0K (+39.5%)
Held since
2024

28 more super investors behind a free account

See every manager holding NRX Pharmaceuticals, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting NRXP on Form N-PORT; together they hold 6.1% of the company
VT
Position value
$5.18M
% of company
2.94%
% of the fund
0.00%
As of
June 30, 2026
AP
AdvisorShares Trust
Position value
$2.7M
% of company
1.53%
% of the fund
6.07%
As of
June 30, 2026

12 more funds behind a free account

See every fund holding NRX Pharmaceuticals, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
JD
Javitt Daniel C.
Insider
Shares
3.7M
% of company
8.50%
Change vs last qtr
—
Held since
—
JJ
Javitt Jonathan C
Insider
Shares
1.7M
% of company
3.84%
Change vs last qtr
—
Held since
—

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support